Conditions: Hepatocellular Carcinoma; Hepatoblastoma
Interventions: Genetic: TEGAR T cells; Drug: Cytoxan; Drug: Fludarabine
Sponsors: Baylor College of Medicine; Texas Children's Hospital; The Methodist Hospital System
Not yet recruiting
Feeds
46329 items (46329 unread) in 74 feeds
Acinar Cell Carcinoma
(291 unread)
Acinic Cell Carcinoma
(221 unread)
Adenoid Cystic Carcinoma
(944 unread)
Adrenal Gland Cancer
(4053 unread)
Ampulla Of Vater
(1080 unread)
Anal Cancer
(4610 unread)
Angiosarcoma
(1409 unread)
Appendix Cancer
(614 unread)
Bile Duct Cancer
(5730 unread)
Brain and CNS
(6144 unread)
Carcinoid
(2008 unread)
Endocrine/Neuroendocrine
(5045 unread)
Gall Bladder Cancer
(2112 unread)
Hemangioendothelioma
(609 unread)
Hepatoblastoma
(672 unread)
Pancreas
(628 unread)
Phyllodes
(357 unread)
PMP and Mucinous Tumors
(420 unread)
Rhabdomyosarcoma
(1785 unread)
Sarcoma
(7597 unread)
Trial - Hepatoblastoma (11 unread)
-
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
Posted: September 18th, 2019, 2:00pm GMT
-
Molecular Basis of Pediatric Liver Cancer
Posted: May 22nd, 2019, 2:00pm GMT
Conditions: Childhood Liver Cancer; Liver Malignant Tumors; Embryonal Sarcoma of Liver (Disorder); Hepatoblastoma; Hepatocellular Carcinoma; Rhabdoid Tumor of Liver
Intervention:
Sponsor: University of Pittsburgh
Recruiting -
Can Pre-operative Flexible 3D Models of Pulmonary Malformations Facilitate Thoracoscopic Resection
Posted: April 12th, 2019, 2:00pm GMT
Condition: Pulmonary Malformation
Interventions: Device: 3D printed model; Other: Control group
Sponsor: Hospices Civils de Lyon
Not yet recruiting -
Diagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic Tumor
Posted: August 24th, 2018, 2:00pm GMT
Conditions: Hepatoblastoma; Hepatic Hemangioendothelioma
Intervention: Diagnostic Test: PIVKA-II
Sponsors: Shanghai Children's Medical Center; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Chidren's Hospital of Fudan University; Chongqing Children's Hospital, Chongqing Medical University; Children’s Hospital of Nanjing Medical University; Qilu Children's Hospital of Shandong University; Anhui Children's Hospital; The First Affiliated Hospital of Anhui Medical University; Zhengzhou Children's Hospital
Recruiting -
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Posted: August 7th, 2018, 2:00pm GMT
Conditions: Pediatric Solid Tumor; Germ Cell Tumor; Retinoblastoma; Hepatoblastoma; Wilms Tumor; Rhabdoid Tumor; Carcinoma; Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma; Clear Cell Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Desmoplastic Small Round Cell Tumor; Soft Tissue Sarcoma; Neuroblastoma
Interventions: Biological: second generation 4-1BBζ EGFR806-EGFRt; Biological: second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
Sponsor: Seattle Children's Hospital
Recruiting -
Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Posted: April 25th, 2018, 2:00pm GMT
Condition: Cancer
Interventions: Drug: Gemcitabine; Drug: Nab-paclitaxel
Sponsors: Emory University; Celgene Corporation
Recruiting -
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Posted: July 11th, 2017, 2:00pm GMT
Conditions: Advanced Malignant Solid Neoplasm; Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; EZH2 Gene Mutation; Low Grade Glioma; Recurrent Central Nervous System Neoplasm; Recurrent Ependymoma; Recurrent Ewing Sarcoma; Recurrent Glioma; Recurrent Hepatoblastoma; Recurrent Hodgkin Lymphoma; Recurrent Langerhans Cell Histiocytosis; Recurrent Malignant Germ Cell Tumor; Recurrent Malignant Glioma; Recurrent Malignant Solid Neoplasm; Recurrent Medulloblastoma; Recurrent Neuroblastoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Osteosarcoma; Recurrent Peripheral Primitive Neuroectodermal Tumor; Recurrent Rhabdoid Tumor; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Refractory Hodgkin Lymphoma; Refractory Langerhans Cell Histiocytosis; Refractory Malignant Germ Cell Tumor; Refractory Malignant Glioma; Refractory Malignant Solid Neoplasm; Refractory Medulloblastoma; Refractory Neuroblastoma; Refractory Non-Hodgkin Lymphoma; Refractory Osteosarcoma; Refractory Peripheral Primitive Neuroectodermal Tumor; Refractory Rhabdoid Tumor; Refractory Soft Tissue Sarcoma; Rhabdoid Tumor; SMARCA4 Gene Inactivation; SMARCB1 Gene Inactivation; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Wilms Tumor
Interventions: Other: Laboratory Biomarker Analysis; Drug: Tazemetostat
Sponsor: National Cancer Institute (NCI)
Recruiting -
Paediatric Hepatic International Tumour Trial
Posted: January 11th, 2017, 3:00pm GMT
Conditions: Hepatoblastoma; Carcinoma, Hepatocellular
Interventions: Drug: Cisplatin; Drug: Doxorubicin; Drug: Carboplatin; Drug: 5Fluorouracil; Drug: Vincristine; Drug: Etoposide; Drug: Irinotecan; Drug: Gemcitabine; Drug: Oxaliplatin; Drug: Sorafenib
Sponsors: University of Birmingham; Fundació Institut Germans Trias i Pujol; University of Padua; University of Newcastle Upon-Tyne; University Hospital Munich; University Hospital, Bonn; University of Kiel; University Hospital Tuebingen; Medical University of Gdansk
Recruiting -
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Posted: March 18th, 2015, 2:00pm GMT
Conditions: Retinoblastoma; Clear Cell Sarcoma; Renal Cell Carcinoma; Rhabdoid Tumor; Wilms Tumor; Hepatoblastoma; Neuroblastoma; Germ Cell Tumors; Ewings Sarcoma; Non-rhabdomyosarcoma Soft Tissue Sarcoma; Osteosarcoma; Rhabdomyosarcoma
Interventions: Drug: Simvastatin; Drug: Cyclophosphamide; Drug: Topotecan; Drug: Myeloid growth factor
Sponsors: Emory University; Children's Healthcare of Atlanta
Recruiting -
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Posted: March 5th, 2013, 3:00pm GMT
Condition: Refractory and/or Relapsed Metastatic Solid Tumors
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Radiation: low dose total body irradiation; Drug: Melphalan; Drug: Tacrolimus
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting -
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Posted: January 6th, 2012, 3:00pm GMT
Conditions: Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors
Interventions: Drug: Ifosfamide; Drug: Etoposide; Drug: Mesna; Biological: G-CSF; Drug: Busulfan; Drug: Melphalan; Drug: Thiotepa; Biological: Autologous stem cell infusion; Radiation: Radiation; Drug: Carboplatin; Drug: Paclitaxel; Procedure: Leukapheresis; Drug: Anti-seizure prophylaxis; Drug: Ursodiol
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting